Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts

Journal of Heart and Lung Transplantation

Volumn 34, Issue 4, 2015, Pages 580-587

  Li, Fang ^a   Wei, Jennifer ^a   Valenzuela, Nicole M ^a   Lai, Chi ^a   Zhang, Qiuheng ^a   Gjertson, David ^a   Fishbein, Michael C ^a   Kobashigawa, Jon A ^b   Deng, Mario ^c   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cedars Sinai Heart Institute   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

antibody mediated rejection; C4d; cardiac allograft; endomyocardial biopsy; S6 kinase

Indexed keywords

HLA ANTIBODY; RIBOSOME PROTEIN; S6 KINASE; S6 RIBOSOMAL PROTEIN; UNCLASSIFIED DRUG; ANTIBODY; BIOLOGICAL MARKER; PROTEIN S6;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BLOOD; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ADULT; ANTIBODIES; BIOMARKERS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES;

EID: 84927972039     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.09.047     Document Type: Article

References (57)

1. G.A. Fishbein, and M.C. Fishbein Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft Hum Immunol 73 2012 1213 1217
2. M. Haas Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum Curr Opin Nephrol Hypertens 21 2012 264 271
3. E.H. Hammond, R.L. Yowell, and S. Nunoda Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications J Heart Transplant 8 1989 430 443
4. M.A. Lones, L.S. Czer, and A. Trento Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients J Heart Lung Transplant 14 1995 151 162
5. E. Loh, J.D. Bergin, and G.S. Couper Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation J Heart Lung Transplant 13 1994 194 201
6. D.O. Taylor, R.L. Yowell, and A.G. Kfoury Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection J Heart Lung Transplant 19 2000 518 521
7. P.J. Michaels, M.L. Espejo, and J. Kobashigawa Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J Heart Lung Transplant 22 2003 58 69
8. P. Aurora, M.M. Boucek, and J. Christie Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report - 2007 J Heart Lung Transplant 26 2007 1223 1228
9. R. Kirk, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twelfth official pediatric heart transplantation report - 2009 J Heart Lung Transplant 28 2009 993 1006
10. D.O. Taylor, J. Stehlik, and L.B. Edwards Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report - 2009 J Heart Lung Transplant 28 2009 1007 1022
11. A. Loupy, G.S. Hill, and C. Suberbielle Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA) Am J Transplant 11 2011 56 65
12. S. Mauiyyedi, M. Crespo, and A.B. Collins Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification J Am Soc Nephrol 13 2002 779 787
13. R.N. Smith, N. Brousaides, and L. Grazette C4d deposition in cardiac allografts correlates with alloantibody J Heart Lung Transplant 24 2005 1202 1210
14. V. Nickeleit, and M.J. Mihatsch Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 18 2003 2232 2239
15. M. Haas C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival Clin Nephrol 75 2011 271 278
16. S.K. Takemoto, A. Zeevi, and S. Feng National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033 1041
17. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
18. F. Li, M.E. Atz, and E.F. Reed Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways Curr Opin Immunol 21 2009 557 562
19. X. Zhang, and E.F. Reed HLA class I: an unexpected role in integrin beta4 signaling in endothelial cells Hum Immunol 73 2012 1239 1244
20. X. Zhang, N.M. Valenzuela, and E.F. Reed HLA class I antibody-mediated endothelial and smooth muscle cell activation Curr Opin Organ Transplant 17 2012 446 451
21. P.T. Jindra, Y.P. Jin, and R. Jacamo MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway Biochem Biophys Res Commun 369 2008 781 787
22. 2+ in human aortic endothelial cells Am J Physiol Cell Physiol 303 2012 C872 C882
23. P.T. Jindra, Y.P. Jin, and E. Rozengurt HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway J Immunol 180 2008 2357 2366
24. F. Li, X.H. Zhang, and Y.P. Jin Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner Hum Immunol 72 2011 1150 1159
25. Y.P. Jin, N.M. Valenzuela, and M.E. Ziegler Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus Am J Transplant 14 2014 806 819
26. E.J. Lepin, Q. Zhang, and X. Zhang Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts Am J Transplant 6 2006 1560 1571
27. J.K. Patel, M. Kittleson, and J.A. Kobashigawa Cardiac allograft rejection Surgeon 9 2011 160 167
28. G.J. Berry, M.M. Burke, and C. Andersen The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation J Heart Lung Transplant 32 2013 1147 1162
29. G.J. Berry, A. Angelini, and M.M. Burke The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011) J Heart Lung Transplant 30 2011 601 611
30. P.T. Jindra, A. Hsueh, and L. Hong Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts J Immunol 180 2008 2214 2224
31. G. Choe, S. Horvath, and T.F. Cloughesy Analysis of the phosphatidylinositol 3-kinase signaling pathway in glioblastoma patients in vivo Cancer Res 63 2003 2742 2746
32. H.L. Kenerson, L.D. Aicher, and L.D. True Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors Cancer Res 62 2002 5645 5650
33. J. Kobashigawa, M.G. Crespo-Leiro, and S.M. Ensminger Report from a consensus conference on antibody-mediated rejection in heart transplantation J Heart Lung Transplant 30 2011 252 269
34. E.K. Ho, G. Vlad, E.R. Vasilescu, and L. de la Torre Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival Hum Immunol 72 2011 5 10
35. I. Kaczmarek, M.A. Deutsch, and T. Kauke Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant Exp Clin Transplant 6 2008 229 235
36. M. McKay, S. Pinney, and S. Gorwara Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy Transplantation 79 2005 1581 1587
37. A.R. Tambur, S.V. Pamboukian, and M.R. Costanzo The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome Transplantation 80 2005 1019 1025
38. S. Jurcevic, M.E. Ainsworth, and A. Pomerance Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation Transplantation 71 2001 886 892
39. M.L. Rose Role of antibodies in transplant-associated cardiac allograft vasculopathy Z Kardiol 89 suppl 9 2000 IX/11 IX/15
40. X. Zhang, and E.F. Reed Effect of antibodies on endothelium Am J Transplant 9 2009 2459 2465
41. M.R. Mehra, M.G. Crespo-Leiro, and A. Dipchand International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy - 2010 J Heart Lung Transplant 29 2011 717 727
42. E.D. Poggio, M. Roddy, and J. Riley Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy J Heart Lung Transplant 24 2005 1606 1613
43. H.O. Ventura, and M.R. Mehra C-reactive protein and cardiac allograft vasculopathy. Is inflammation the critical link? J Am Coll Cardiol 42 2003 483 485
44. M. Tible, A. Loupy, and D. Vernerey Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation J Heart Lung Transplant 32 2013 769 776
45. Y.P. Jin, R.P. Singh, and Z.Y. Du Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner J Immunol 168 2002 5415 5423
46. Y.P. Jin, M.C. Fishbein, and J.W. Said Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells Hum Immunol 65 2004 291 302
47. Y.P. Jin, Y. Korin, and X. Zhang RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells J Immunol 178 2007 7911 7922
48. X. Zhang, E. Rozengurt, and E.F. Reed HLA class I molecules partner with integrin beta4 to stimulate endothelial cell proliferation and migration Sci Signal 2010 3 ra85
49. W.M. Baldwin III, E.K. Kasper, and A.A. Zachary Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection Am J Transplant 4 2004 311 318
50. C.N. Morrell, K. Murata, and A.M. Swaim In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody Circ Res 102 2008 777 785
51. N.M. Valenzuela, A. Mulder, and E.F. Reed HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcgammaRs J Immunol 190 2013 6635 6650
52. T.R. Fenton, and I.T. Gout Functions and regulation of the 70kDa ribosomal S6 kinases Int J Biochem Cell Biol 43 2011 47 59
53. I. Ruvinsky, and O. Meyuhas Ribosomal protein S6 phosphorylation: from protein synthesis to cell size Trends Biochem Sci 31 2006 342 348
54. M.E. Ziegler, P. Souda, and Y.P. Jin Characterization of the endothelial cell cytoskeleton following HLA class I ligation PloS One 7 2012 e29472
55. J.H. Fox, T. Connor, and V. Chopra The mTOR kinase inhibitor everolimus decreases S6 kinase phosphorylation but fails to reduce mutant Huntington levels in brain and is not neuroprotective in the R6/2 mouse model of Huntingtons disease Mol Neurodegener 5 2010 26
56. H.J. Eisen, E.M. Tuzcu, and R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847 858
57. H. Lehmkuhl, H. Ross, and H. Eisen Everolimus (Certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure Transplant Proc 37 2005 4145 4149